COCP MRNA Jump On Coronavirus Update LPCN Making 4th Try NGM Up On NASH Data

COCP, MRNA Jump On Coronavirus Update, LPCN Making 4th Try, NGM Up On NASH Data

23:34 EST 24 Feb 2020 | RTTNews

Today's Daily Dose brings you news about NGM Biopharma's phase II NASH study results, Moderna's Coronavirus program, COCRYSTAL's focus on COVID-19 coronavirus and norovirus, Lipocine's update on the New Drug Application of TLANDO, growing woes of Mallinckrodt, and Takeda Pharma's date with FDA, among others.

COCP MRNA Jump On Coronavirus Update LPCN Making 4th Try NGM Up On NASH Data

COCP, MRNA Jump On Coronavirus Update, LPCN Making 4th Try, NGM Up On NASH Data

More From BioPortfolio on "COCP, MRNA Jump On Coronavirus Update, LPCN Making 4th Try, NGM Up On NASH Data"